Partnership to utilize IRIS Registry database to advance patient care.
RPB-supported researchers made a critical discovery about the gene mutation that causes many retinal degenerative diseases, opening the door for a new line of research into potential treatments.
RPB-supported researchers make progress in characterizing the genetic components of Usher syndrome.
The model will allow researchers to better assess treatments for this hard-to-study cause of blindness.
The findings may have significant therapeutic implications for AMD, the most common cause of elderly blindness in the developed world
RPB-supported researchers at the University of Illinois at Chicago have identified an enzyme present in the cornea that triggers inflammation during and even after a herpes virus infection.
New RPB-supported research provides hope for transplants of neural stem cells as future treatment for brain injuries.
Dry eye, a global problem affecting more than 30 million people in the U.S. alone, occurs when the eye does not produce tears properly or when the tears are not of the correct consistency and evaporate too quickly.
The RPB-supported researchers hope their finding will lead to tests to identify cell damage before irreversible vision loss.
More than 30 private and public funders of vision research came together in Washington DC to discuss ways to maximize their support of scientific research in light of new recommendations and a changing environment.
|General Info||Research Scientists & Grantees||Eye Care Specialists||Donors & Partners|